Stevanato (STVN) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
1.1B
Gross Profit
302.3M
27.38%
Operating Income
161.1M
14.60%
Net Income
117.8M
10.67%
EPS (Diluted)
$0.43
Balance Sheet Metrics
Total Assets
2.3B
Total Liabilities
924.4M
Shareholders Equity
1.4B
Debt to Equity
0.66
Cash Flow Metrics
Operating Cash Flow
222.5M
Free Cash Flow
-157.8M
Revenue & Profitability Trend
Stevanato Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 1.1B | 1.1B | 983.7M | 843.9M | 662.0M |
| Cost of Goods Sold | 801.7M | 745.5M | 663.9M | 578.5M | 467.9M |
| Gross Profit | 302.3M | 339.9M | 319.8M | 265.4M | 194.2M |
| Operating Expenses | 141.2M | 139.2M | 127.4M | 103.2M | 91.1M |
| Operating Income | 161.1M | 200.7M | 192.4M | 162.2M | 103.1M |
| Pre-tax Income | 160.3M | 189.6M | 187.6M | 165.7M | 96.3M |
| Income Tax | 42.5M | 43.9M | 44.6M | 31.4M | 17.7M |
| Net Income | 117.8M | 145.7M | 143.0M | 134.3M | 78.6M |
| EPS (Diluted) | $0.43 | $0.55 | $0.54 | $0.53 | $0.27 |
Income Statement Trend
Stevanato Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 880.1M | 861.9M | 845.8M | 866.0M | 492.8M |
| Non-Current Assets | 1.4B | 1.2B | 813.9M | 552.9M | 475.2M |
| Total Assets | 2.3B | 2.1B | 1.7B | 1.4B | 968.0M |
| Liabilities | |||||
| Current Liabilities | 477.5M | 574.4M | 462.5M | 338.6M | 316.2M |
| Non-Current Liabilities | 447.0M | 364.5M | 201.3M | 238.6M | 341.7M |
| Total Liabilities | 924.4M | 938.9M | 663.8M | 577.2M | 657.8M |
| Equity | |||||
| Total Shareholders Equity | 1.4B | 1.1B | 995.9M | 841.7M | 310.1M |
Balance Sheet Composition
Stevanato Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 160.3M | 189.6M | 187.6M | 165.7M | 96.3M |
| Operating Cash Flow | 222.5M | 182.3M | 141.7M | 175.8M | 188.1M |
| Investing Activities | |||||
| Capital Expenditures | -299.5M | -432.7M | -234.9M | -106.5M | -89.6M |
| Investing Cash Flow | -299.6M | -408.3M | -234.9M | -90.9M | -89.6M |
| Financing Activities | |||||
| Dividends Paid | -14.5M | -14.3M | -13.5M | -11.2M | -8.9M |
| Financing Cash Flow | 183.2M | 158.0M | -44.5M | 254.8M | -26.5M |
| Free Cash Flow | -157.8M | -336.7M | -139.8M | 20.2M | 59.7M |
Cash Flow Trend
Stevanato Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
44.23
Forward P/E
39.07
Price to Book
4.52
Price to Sales
5.69
PEG Ratio
39.07
Profitability Ratios
Profit Margin
11.16%
Operating Margin
13.97%
Return on Equity
9.14%
Return on Assets
4.88%
Financial Health
Current Ratio
1.82
Debt to Equity
27.86
Beta
0.53
Per Share Data
EPS (TTM)
$0.53
Book Value per Share
$5.19
Revenue per Share
$4.12
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| stvn | 6.4B | 44.23 | 4.52 | 9.14% | 11.16% | 27.86 |
| Intuitive Surgical | 189.7B | 77.39 | 11.09 | 15.96% | 28.41% | 0.00 |
| Becton, Dickinson | 50.0B | 33.87 | 1.98 | 5.89% | 7.18% | 76.34 |
| Avantor | 9.2B | 13.05 | 1.52 | 12.52% | 10.70% | 67.34 |
| Repligen | 6.9B | 511.11 | 3.49 | -1.16% | -3.53% | 34.44 |
| Merit Medical | 5.5B | 45.25 | 3.82 | 9.16% | 8.81% | 57.24 |
Financial data is updated regularly. All figures are in the company's reporting currency.